FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 351:2865-2867 December 30, 2004 Number 27 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Paik, S. PubMed Citation

During the past two decades, molecular biologists have been dissecting the heterogeneity of human cancer — a diversity that oncologists have long appreciated, especially because patients who have similar stages and grades of cancer and whose tumors have similar histologic features have a broad range of clinical outcomes. Some cancers respond to treatment; others do not. Some patients have a recurrence of cancer; others are cured.

Molecular markers promise the ability to estimate prognoses and predict responses to particular treatments with greater precision than is possible with clinical findings. With further refinement of molecular diagnostics, the care of patients with . . . [Full Text of this Article]

Source Information

From the Departments of Experimental Therapeutics (R.C.B.) and Breast Medical Oncology (G.N.H.), University of Texas M.D. Anderson Cancer Center, Houston.

Related Letters:

Molecular Prediction of Recurrence of Breast Cancer
Geradts J., Goodson W. H. III, Tang C. G., Lin A. Y., Tanvetyanon T., Paik S., Wolmark N., Shak S., Bast R. C. Jr., Hortobagyi G. N.
Extract | Full Text | PDF  
N Engl J Med 2005; 352:1605-1607, Apr 14, 2005. Correspondence

This article has been cited by other articles:

• Ellis, M. J., Tao, Y., Luo, J., A'Hern, R., Evans, D. B., Bhatnagar, A. S., Chaudri Ross, H. A., von Kameke, A., Miller, W. R., Smith, I., Eiermann, W., Dowsett, M. (2008). Outcome Prediction for Estrogen Receptor-Positive Breast Cancer Based on Postneoadjuvant Endocrine Therapy Tumor Characteristics. JNCI J Natl Cancer Inst 100: 1380-1388 [Abstract] [Full Text]  
• Chen, H.-Y., Yu, S.-L., Chen, C.-H., Chang, G.-C., Chen, C.-Y., Yuan, A., Cheng, C.-L., Wang, C.-H., Terng, H.-J., Kao, S.-F., Chan, W.-K., Li, H.-N., Liu, C.-C., Singh, S., Chen, W. J., Chen, J. J.W., Yang, P.-C. (2007). A Five-Gene Signature and Clinical Outcome in Non-Small-Cell Lung Cancer. NEJM 356: 11-20 [Abstract] [Full Text]  
• Travis, L. B., Rabkin, C. S., Brown, L. M., Allan, J. M., Alter, B. P., Ambrosone, C. B., Begg, C. B., Caporaso, N., Chanock, S., DeMichele, A., Figg, W. D., Gospodarowicz, M. K., Hall, E. J., Hisada, M., Inskip, P., Kleinerman, R., Little, J. B., Malkin, D., Ng, A. K., Offit, K., Pui, C.-H., Robison, L. L., Rothman, N., Shields, P. G., Strong, L., Taniguchi, T., Tucker, M. A., Greene, M. H. (2006). Cancer Survivorship--Genetic Susceptibility and Second Primary Cancers: Research Strategies and Recommendations. JNCI J Natl Cancer Inst 98: 15-25 [Abstract] [Full Text]  
• Insel, T. R., Quirion, R. (2005). Psychiatry as a Clinical Neuroscience Discipline. JAMA 294: 2221-2224 [Full Text]  
• Geradts, J., Goodson, W. H. III, Tang, C. G., Lin, A. Y., Tanvetyanon, T., Paik, S., Wolmark, N., Shak, S., Bast, R. C. Jr., Hortobagyi, G. N. (2005). Molecular Prediction of Recurrence of Breast Cancer. NEJM 352: 1605-1607 [Full Text]  
• (2005). Predicting Breast Cancer Recurrence with a Multigene Assay. JWatch Women's Health 2005: 4-4 [Full Text]